Sanford C. Bernstein set a CHF 284 price objective on Roche Holding Ltd. (VTX:ROG) in a research report sent to investors on Thursday. The brokerage currently has a buy rating on the healthcare company’s stock.

ROG has been the topic of several other reports. HSBC Holdings plc set a CHF 215 price target on Roche Holding and gave the company a sell rating in a research note on Tuesday, July 11th. Jefferies Group LLC set a CHF 305 price target on Roche Holding and gave the company a buy rating in a research note on Monday, May 29th. Goldman Sachs Group, Inc. (The) set a CHF 335 price target on Roche Holding and gave the company a buy rating in a research note on Friday, May 26th. Kepler Capital Markets set a CHF 231 price target on Roche Holding and gave the company a neutral rating in a research note on Tuesday, June 6th. Finally, Deutsche Bank AG set a CHF 273 price target on Roche Holding and gave the company a buy rating in a research note on Tuesday, June 27th. One analyst has rated the stock with a sell rating, six have given a hold rating and seven have assigned a buy rating to the company. Roche Holding currently has a consensus rating of Hold and an average price target of CHF 271.08.

Shares of Roche Holding (VTX ROG) opened at 242.50 on Thursday. The company’s 50-day moving average price is CHK 246.69 and its 200-day moving average price is CHK 251.11. Roche Holding has a 1-year low of CHK 218.30 and a 1-year high of CHK 273.00. The company has a market capitalization of CHK 206.88 billion and a PE ratio of 20.49.

COPYRIGHT VIOLATION WARNING: “Roche Holding Ltd. (ROG) Given a CHF 284 Price Target by Sanford C. Bernstein Analysts” was reported by Watch List News and is the property of of Watch List News. If you are accessing this article on another publication, it was copied illegally and republished in violation of US and international copyright and trademark legislation. The legal version of this article can be viewed at https://www.watchlistnews.com/roche-holding-ltd-rog-given-a-chf-284-price-target-by-sanford-c-bernstein-analysts/1462958.html.

About Roche Holding

Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.

Analyst Recommendations for Roche Holding (VTX:ROG)

Receive News & Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related companies with Analyst Ratings Network's FREE daily email newsletter.